DK0596326T3 - Aryliden-1-azacycloalkaner og arylalkyl-1-azacycloalkaner og salte deraf, lægemidler indeholdende forbindelserne og forbindelsernes anvendelse samt fremgangsmåde til fremstilling af forbindelserne - Google Patents

Aryliden-1-azacycloalkaner og arylalkyl-1-azacycloalkaner og salte deraf, lægemidler indeholdende forbindelserne og forbindelsernes anvendelse samt fremgangsmåde til fremstilling af forbindelserne

Info

Publication number
DK0596326T3
DK0596326T3 DK93116959.3T DK93116959T DK0596326T3 DK 0596326 T3 DK0596326 T3 DK 0596326T3 DK 93116959 T DK93116959 T DK 93116959T DK 0596326 T3 DK0596326 T3 DK 0596326T3
Authority
DK
Denmark
Prior art keywords
compounds
azacycloalkanes
arylidene
arylalkyl
salts
Prior art date
Application number
DK93116959.3T
Other languages
Danish (da)
English (en)
Inventor
Roland Dr Dipl-Chem Maier
Peter Dr Dipl-Chem Mueller
Eberhard Dr Dipl-Chem Woitun
Rudolf Dr Dipl-Chem Hurnaus
Michael Dr Mark
Bernhard Dr Dipl-Chem Eisele
Ralph-Michael Dr Dip Budzinski
Gerhard Dr Dipl-Ch Hallermayer
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4235590A external-priority patent/DE4235590A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Application granted granted Critical
Publication of DK0596326T3 publication Critical patent/DK0596326T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ink Jet (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93116959.3T 1992-10-22 1993-10-20 Aryliden-1-azacycloalkaner og arylalkyl-1-azacycloalkaner og salte deraf, lægemidler indeholdende forbindelserne og forbindelsernes anvendelse samt fremgangsmåde til fremstilling af forbindelserne DK0596326T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4235590A DE4235590A1 (de) 1992-10-22 1992-10-22 Aryliden-l-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4303840A DE4303840A1 (de) 1992-10-22 1993-02-10 Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
DK0596326T3 true DK0596326T3 (da) 1996-01-15

Family

ID=25919689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93116959.3T DK0596326T3 (da) 1992-10-22 1993-10-20 Aryliden-1-azacycloalkaner og arylalkyl-1-azacycloalkaner og salte deraf, lægemidler indeholdende forbindelserne og forbindelsernes anvendelse samt fremgangsmåde til fremstilling af forbindelserne

Country Status (21)

Country Link
EP (1) EP0596326B1 (cs)
JP (1) JP3396517B2 (cs)
KR (1) KR100306520B1 (cs)
CN (1) CN1040873C (cs)
AT (1) ATE126797T1 (cs)
AU (1) AU665648B2 (cs)
CA (1) CA2108817C (cs)
CZ (1) CZ286025B6 (cs)
DE (2) DE4303840A1 (cs)
DK (1) DK0596326T3 (cs)
ES (1) ES2078787T3 (cs)
FI (1) FI934665L (cs)
GR (1) GR3017692T3 (cs)
HK (1) HK1000285A1 (cs)
HU (1) HU221630B1 (cs)
IL (1) IL107342A (cs)
NO (1) NO300843B1 (cs)
NZ (1) NZ250018A (cs)
PL (1) PL173775B1 (cs)
RU (1) RU2126400C1 (cs)
SK (1) SK281222B6 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4234295A1 (de) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
DE19754795A1 (de) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US6228868B1 (en) 1998-07-27 2001-05-08 Abbott Laboratories Oxazoline antiproliferative agents
WO2000006556A1 (en) * 1998-07-27 2000-02-10 Abbott Laboratories Substituted oxazolines as antiproliferative agents
CA2481313A1 (en) 2002-04-12 2003-10-23 Merck & Co., Inc. Bicyclic amides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863932A (en) * 1988-03-11 1989-09-05 Somatogenetics International, Inc. Squalene oxide cyclase inhibitors and therapeutic use thereof
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
ZA915660B (en) * 1990-07-24 1992-05-27 Merrell Dow Pharma Novel substituted piperidines and their use as inhibitors of cholesterol synthesis
ZA915659B (en) * 1990-07-25 1992-05-27 Merrell Dow Pharma Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
PL173775B1 (pl) 1998-04-30
ES2078787T3 (es) 1995-12-16
CN1040873C (zh) 1998-11-25
CZ286025B6 (cs) 1999-12-15
ATE126797T1 (de) 1995-09-15
CZ223693A3 (en) 1994-05-18
EP0596326B1 (de) 1995-08-23
GR3017692T3 (en) 1996-01-31
FI934665A0 (fi) 1993-10-22
SK281222B6 (sk) 2001-01-18
AU665648B2 (en) 1996-01-11
CA2108817A1 (en) 1994-04-23
DE59300507D1 (de) 1995-09-28
AU4913593A (en) 1994-05-05
NO933790D0 (no) 1993-10-21
NO933790L (no) 1994-04-25
HUT68958A (en) 1995-08-28
IL107342A (en) 1997-07-13
HU221630B1 (hu) 2002-12-28
HU9302986D0 (en) 1994-01-28
HK1000285A1 (en) 1998-02-20
CN1090849A (zh) 1994-08-17
EP0596326A1 (de) 1994-05-11
FI934665A7 (fi) 1994-04-23
DE4303840A1 (de) 1994-08-11
IL107342A0 (en) 1994-01-25
CA2108817C (en) 2004-12-07
JP3396517B2 (ja) 2003-04-14
JPH06192256A (ja) 1994-07-12
KR100306520B1 (ko) 2001-11-30
FI934665L (fi) 1994-04-23
NZ250018A (en) 1995-07-26
SK107393A3 (en) 1994-09-07
PL300834A1 (en) 1994-05-16
KR940009181A (ko) 1994-05-20
RU2126400C1 (ru) 1999-02-20
NO300843B1 (no) 1997-08-04

Similar Documents

Publication Publication Date Title
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO302884B1 (no) Krystallinske 3,4,4-trisubstituert-piperidinyl-N-alkylkarboksylater og mellomprodukter, fremgangsmåte for fremstilling av de krystallinske karboksylatene, farmasöytiske preparater inneholdende disse og deres anvendelse
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
ATE269290T1 (de) Benzoylderivate
DK0612322T3 (da) Fremgangsmåde til adskillelse af 5-methyl-tetrahydrofolsyre
NO180679C (no) Pyranylcyanoguanidin-derivater, preparater som inneholder dem og anvendelse derav
DK0404283T3 (da) 11alfa-aryl-4-estrener, fremgangsmåde til fremstilling af disse samt deres anvendelse som lægemidler
DK0532515T3 (da) Fremstilling af substituerede piperidiner
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
BR9206823A (pt) Preparação de piperidinas substituídas
DK243989A (da) Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphthalener, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler indeholdende disse
DK0596326T3 (da) Aryliden-1-azacycloalkaner og arylalkyl-1-azacycloalkaner og salte deraf, lægemidler indeholdende forbindelserne og forbindelsernes anvendelse samt fremgangsmåde til fremstilling af forbindelserne
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
ATE113628T1 (de) Ammonium-verbindung, diese enthaltende zusammensetzung und desinfektionsverfahren.
ITMI911853A1 (it) Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
IL85425A (en) Anticonvulsant compositions containing substituted benzoyl anilides, some such novel compounds and process for their preparation
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DK47988D0 (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
BR9100488A (pt) Processo para a preparacao de compostos,composicao para o combate ou inibicao de uma infestacao por microorganismos
DK0611755T3 (da) Hidtil ukendte (cyklohexyl)alkenforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0433978T3 (da) Fremgangsmåde til fremstilling af nojirimycin og beslægtede forbindelser